Condensed Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)	Total	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]
Beginning Balance at Dec. 31, 2023	$ (2,579,537)	$ 28	$ 120,859,873	$ (123,439,438)
Beginning Balance, Shares at Dec. 31, 2023		278,558
Stock-based compensation expense	254,029		254,029
Issuance of common stock, Pre-Funded Warrants, Series A Warrants, Series B Warrants, and Series C Warrants, net of issuance costs	6,172,623	$ 43	6,172,580
Issuance of common stock, Pre-Funded Warrants, Series A Warrants, Series B Warrants, and Series C Warrants, net of issuance costs, shares		427,886
Amendment and issuance of common stock from Amendment of Series B Warrants and Series C Warrants, net of issuance costs	1,229,874	$ 1	1,229,873
Amendment and issuance of common stock and Pre-Funded Warrants from the March 2024 Amendment of Series B Warrants and Series C Warrants, net of issuance costs, shares		9,967
Net loss	(1,579,820)			(1,579,820)
Ending Balance at Mar. 31, 2024	3,497,169	$ 72	128,516,355	(125,019,258)
Ending Balance, Shares at Mar. 31, 2024		716,411
Beginning Balance at Dec. 31, 2023	(2,579,537)	$ 28	120,859,873	(123,439,438)
Beginning Balance, Shares at Dec. 31, 2023		278,558
Net loss	(4,159,428)
Ending Balance at Sep. 30, 2024	4,387,136	$ 89	131,985,913	(127,598,866)
Ending Balance, Shares at Sep. 30, 2024		894,843
Beginning Balance at Mar. 31, 2024	3,497,169	$ 72	128,516,355	(125,019,258)
Beginning Balance, Shares at Mar. 31, 2024		716,411
Stock-based compensation expense	126,578		126,578
Issuance of common stock from cashless exercise of Pre-Funded Warrants, Shares		18,425
Issuance of common stock from cashless exercise of Pre-Funded Warrants		$ 1	(1)
Amendment and issuance of common stock from Amendment of Series B Warrants and Series C Warrants, net of issuance costs	308,429		308,429
Net loss	(1,267,218)			(1,267,218)
Ending Balance at Jun. 30, 2024	2,664,958	$ 73	128,951,361	(126,286,476)
Ending Balance, Shares at Jun. 30, 2024		734,836
Stock-based compensation expense	131,587		131,587
Amendment and issuance of common stock from the September 2024 Exercise Price Warrant Amendment of Series A Warrants and Series C, Shares Warrants, net of issuance costs, Shares		24,509
Amendment and issuance of common stock from the September 2024 Exercise Price Warrant Amendment of Series A Warrants and Series C Warrants, net of issuance costs	2,532,449	$ 3	2,532,446
Amendment and issuance of common stock from the September 2024 Amendment of Series B Warrants and Series C Warrants, net of issuance costs, Shares		51,062
Amendment and issuance of common stock from the September 2024 Amendment of Series B Warrants and Series C Warrants, net of issuance costs	370,622	$ 5	370,617
Issuance of common stock from the exercise of Pre-Funded Warrants	101	$ 8	93
Issuance of common stock from the exercise of Pre-Funded Warrants, shares		84,436
Redemption of fractional shares due to reverse stock split Net loss	(191)		(191)
Net loss	(1,312,390)			(1,312,390)
Ending Balance at Sep. 30, 2024	4,387,136	$ 89	131,985,913	(127,598,866)
Ending Balance, Shares at Sep. 30, 2024		894,843
Beginning Balance at Dec. 31, 2024	$ 7,038,010	$ 149	135,829,493	(128,791,632)
Beginning Balance, Shares at Dec. 31, 2024	1,486,009	1,486,009
Stock-based compensation expense	$ 84,384		84,384
Issuance of common stock pursuant to the ESPP	24,999		24,999
Issuance of common stock pursuant to the ESPP, Shares		6,849
Net loss	(1,306,178)			(1,306,178)
Ending Balance at Mar. 31, 2025	5,841,215	$ 149	135,938,876	(130,097,810)
Ending Balance, Shares at Mar. 31, 2025		1,492,858
Beginning Balance at Dec. 31, 2024	$ 7,038,010	$ 149	135,829,493	(128,791,632)
Beginning Balance, Shares at Dec. 31, 2024	1,486,009	1,486,009
Net loss	$ (4,033,362)
Ending Balance at Sep. 30, 2025	$ 3,362,236	$ 172	136,187,058	(132,824,994)
Ending Balance, Shares at Sep. 30, 2025	1,722,409	1,722,409
Beginning Balance at Mar. 31, 2025	$ 5,841,215	$ 149	135,938,876	(130,097,810)
Beginning Balance, Shares at Mar. 31, 2025		1,492,858
Stock-based compensation expense	104,253		104,253
Net loss	(1,570,976)			(1,570,976)
Ending Balance at Jun. 30, 2025	4,374,492	$ 149	136,043,129	(131,668,786)
Ending Balance, Shares at Jun. 30, 2025		1,492,858
Stock-based compensation expense	105,056		105,056
Issuance of common stock pursuant to the ESPP	38,896	$ 1	38,895
Issuance of common stock pursuant to the ESPP, Shares		12,588
Issuance of common stock from cashless exercise of Pre-Funded Warrants, Shares		94,646
Issuance of common stock from cashless exercise of Pre-Funded Warrants		$ 10	(10)
Issuance of common stock upon cashless exercise of Modified Series A Warrants, Shares		122,317
Issuance of common stock upon cashless exercise of Modified Series A Warrants		$ 12	(12)
Net loss	(1,156,208)			(1,156,208)
Ending Balance at Sep. 30, 2025	$ 3,362,236	$ 172	$ 136,187,058	$ (132,824,994)
Ending Balance, Shares at Sep. 30, 2025	1,722,409	1,722,409